NCT05957809

Brief Summary

the effectiveness of structured exercise training will be investigated for individuals with MS who are newly diagnosed and have no clinical problems. Individuals with MS included in the study will be randomly divided into two groups a Structured Exercise Group (SEG) and a Control Group (CG). In order to compare baseline and follow-up data, the Healthy Group (HG) will be taken and all three groups will be evaluated initially, 8. weeks and 24. weeks with primary and secondary outcome measurements. SEG, CG, and HG will be evaluated initially for postural sway, muscle strength, mobility, dexterity, cognitive function, trunk strength-endurance, and fatigue. Afterward, SEG will receive structured exercise training consisting of clinically supervised aerobic exercise and resistance training on unstable surfaces for 8 weeks, 2 days a week, with a minimum session duration of 60 minutes. Stretching and mobility exercises will be added to warm up and cool down before and after the program. CG will be on the waiting list during this process. At the end of 8 weeks, both groups will be reassessed with their initial assessment. After the 8-week program, the SEG physical activity recommendation will be given and the KG group will continue on the waiting list, and a follow-up evaluation will be made in the 24th week. This study will allow the comparison of newly diagnosed individuals with MS who do not have any physical or cognitive effects on neurological examination and healthy controls with objective and detailed evaluations, and will also reveal the evidence on the effects of planned structured exercises specific to individuals with newly diagnosed MS. During the 24-week follow-up period, the change in the clinical status of individuals with MS who received or did not receive any exercise training can be interpreted.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

July 20, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 24, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2025

Completed
Last Updated

May 25, 2025

Status Verified

May 1, 2025

Enrollment Period

1.7 years

First QC Date

June 20, 2023

Last Update Submit

May 21, 2025

Conditions

Keywords

Multiple sclerosisnewly diagnosisexercisepostural swaycognition

Outcome Measures

Primary Outcomes (4)

  • Clinical Test of Sensory Integration of Balance Test

    Postural sway in "open eyes-firm surface, closed eyes-firm surface, open eyes-foam surface, closed eyes-foam surface" conditions will be evaluated with the Clinical Test of Sensory Integration of Balance.

    24 weeks

  • Postural Stability Test

    Anterior-posterior, mediolateral and overall sway will be evaluated with the Postural Stability Test in Biodex Balance System.

    24 weeks

  • Balance Error Scoring System Test

    Postural sway in tandem position and feet together position will be evaluated with Balance Error Scoring System in Biodex Balance System.

    24 weeks

  • Muscle strength

    Quadriceps, hamstring, ankle dorsi and plantar flexors muscle strength will be assessed with Hand Held Dynamometer.

    24 weeks

Secondary Outcomes (4)

  • 2 Minute Walk Test

    Baseline, 8th and 24th weeks

  • Timed 25 Foot Walk Test

    Baseline, 8th and 24th weeks

  • Brief International Cognitive Assessment for MS (BICAMS)

    Baseline, 8th and 24th weeks

  • Curl-up

    Baseline, 8th and 24th weeks

Study Arms (2)

1. Structured exercise group

EXPERIMENTAL

This group will receive structured exercise training with 60-75 minute sessions per day, 2 days a week, for 8 weeks.

Other: Structured exercise training

2. Control group

NO INTERVENTION

This group will be assessed at the beginning, 8. and 24. weeks.

Interventions

This group will receive structured exercise training with 60-75 minute sessions per day, 2 days a week, for 8 weeks. • Warm-up program - 10 minutes * Strength training on unstable surfaces - 25-30 minutes * High repetition muscular endurance training - 25-30 minutes * Cool-down program - 10 minutes

1. Structured exercise group

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being diagnosed with MS according to McDonald diagnostic criteria
  • EDSS below 2.5
  • Diagnosis period less than 1 year
  • Being between the ages of 18-45
  • Volunteering to participate in the study

You may not qualify if:

  • Apart from the MS diagnosis, orthopedic, neurological, psychological, etc., which will affect the evaluation results. have diseases
  • Regular exercise and doing sports
  • Being involved in another rehabilitation program
  • Being pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Feray Güngör

Istanbul, 34147, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Multiple SclerosisMotor Activity

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 20, 2023

First Posted

July 24, 2023

Study Start

July 20, 2023

Primary Completion

March 20, 2025

Study Completion

May 20, 2025

Last Updated

May 25, 2025

Record last verified: 2025-05

Locations